Evolent Health, Inc. Quarterly Amortization of Intangible Assets in USD from Q1 2015 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary: Evolent Health, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2015 to Q2 2024.
Evolent Health, Inc. Amortization of Intangible Assets for the quarter ending June 30, 2024 was $22M, a 8.33% decline year-over-year.
Evolent Health, Inc. Amortization of Intangible Assets for the twelve months ending June 30, 2024 was $89.9M, a 37.3% increase year-over-year.
Evolent Health, Inc. annual Amortization of Intangible Assets for 2023 was $91M, a 159% increase from 2022.
Evolent Health, Inc. annual Amortization of Intangible Assets for 2022 was $35.2M, a 19.7% increase from 2021.
Evolent Health, Inc. annual Amortization of Intangible Assets for 2021 was $29.4M, a 8.98% decline from 2020.

Amortization of Intangible Assets, Trailing 12 Months (USD)

Amortization of Intangible Assets, Quarterly (USD)

Amortization of Intangible Assets, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$89.9M	$22M	-$2M	-8.33%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-09
Q1 2024	$91.9M	$22M	+$900K	+4.27%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-10
Q4 2023	$91M	$22.1M	+$11.2M	+103%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-23
Q3 2023	$79.8M	$23.8M	+$14.3M	+151%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-02
Q2 2023	$65.5M	$24M	+$16.7M	+229%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-09
Q1 2023	$48.8M	$21.1M	+$13.6M	+181%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-10
Q4 2022	$35.2M	$10.9M	+$3.6M	+49.3%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-23
Q3 2022	$31.6M	$9.5M	+$2.1M	+28.4%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-02
Q2 2022	$29.5M	$7.3M	+$100K	+1.39%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-03
Q1 2022	$29.4M	$7.5M	$0	0%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-04
Q4 2021	$29.4M	$7.3M	-$100K	-1.35%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-23
Q3 2021	$29.5M	$7.4M	+$200K	+2.78%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	$29.3M	$7.2M	-$1.2M	-14.3%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-03
Q1 2021	$30.5M	$7.5M	-$1.8M	-19.4%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-05
Q4 2020	$32.3M	$7.4M	-$1.6M	-17.8%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-24
Q3 2020	$33.9M	$7.2M	-$2.2M	-23.4%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-04
Q2 2020	$36.1M	$8.4M	-$1.2M	-12.5%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020	$37.3M	$9.3M	+$200K	+2.2%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	$37.1M	$9M	-$200K	-2.17%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-24
Q3 2019	$37.3M	$9.4M	+$3.3M	+54.1%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-06
Q2 2019	$34M	$9.6M	+$3.6M	+60%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-10
Q1 2019	$30.4M	$9.1M	+$3.2M	+54.2%	Jan 1, 2019	Mar 31, 2019	10-Q	2019-05-09
Q4 2018	$27.2M	$9.2M	+$1.4M	+17.9%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-26
Q3 2018	$25.8M	$6.1M	+$800K	+15.1%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-05
Q2 2018	$25M	$6M	+$1.1M	+22.4%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-09
Q1 2018	$23.9M	$5.9M	+$1.1M	+22.9%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-09
Q4 2017	$22.8M	$7.8M	+$3.2M	+69.6%	Oct 1, 2017	Dec 31, 2017	10-K	2020-03-02
Q3 2017	$19.6M	$5.3M	+$2.6M	+96.3%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-08
Q2 2017	$17M	$4.9M	+$2.3M	+88.5%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-09
Q1 2017	$14.7M	$4.8M	+$2.2M	+84.6%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-10
Q4 2016	$12.5M	$4.6M	+$2.1M	+84%	Oct 1, 2016	Dec 31, 2016	10-K	2019-02-28
Q3 2016	$10.4M	$2.7M	+$200K	+8%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-09
Q2 2016	$10.2M	$2.6M	+$1.8M	+225%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-07
Q1 2016	$8.4M	$2.6M	+$2.6M		Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-10
Q4 2015	$5.8M	$2.5M			Oct 1, 2015	Dec 31, 2015	10-K	2018-03-01
Q3 2015		$2.5M			Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-10
Q2 2015		$800K			Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-09
Q1 2015		$0			Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-16

* An asterisk sign (*) next to the value indicates that the value is likely invalid.